David Miyamoto

David Miyamoto, MD, PhD is an Assistant Professor of Radiation Oncology at Harvard Medical School, an attending radiation oncologist at the Massachusetts General Hospital, an Investigator in the Mass General Center for Cancer Research, and an Associate Member of the Broad Institute of Harvard and MIT. Dr. Miyamoto received his undergraduate degree in Chemistry from Harvard College, MD from Harvard Medical School, and PhD in Cell Biology from Harvard University. He completed his internship in Internal Medicine at the Brigham & Women's Hospital and his residency in the Harvard Radiation Oncology Program. Dr. Miyamoto is a board-certified radiation oncologist specializing in genitourinary malignancies who sees patients in the Bertucci Center for Genitourinary Cancers at the Mass General Cancer Center and the Department of Radiation Oncology. His research efforts focus on the development of novel biomarkers to guide prostate cancer and bladder cancer therapy and improve the individualized care of each patient. He has authored more than 40 publications in peer-reviewed scientific journals including Science, Cell, and Cancer Discovery. His research has been supported by the Prostate Cancer Foundation, Department of Defense, National Cancer Institute, and the Dana Farber/Harvard Cancer Center.

Clinical Interests:

• Bladder cancer
• Intensity modulated radiation therapy (IMRT)
• Prostate cancer
• Proton Beam Therapy
• Proton therapy
• Renal Cancer
• Testicular cancer